Have your own idea? Try our Stock Screener
UPDATED Jan 20, 2025
Discover Belgian Pharmaceuticals & Biotech Growth Stocks that are on the BEL20. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
ARGX | €634.40 | -1.9% | 89.4% | €38.3b | €624.47 | PS20.9x | E41.9% | n/a | ||
UCB | €183.15 | -4.2% | 117.6% | €34.7b | €193.94 | PE144.8x | E28.4% | 0.7% | ||
HYL | €5.80 | -4.6% | -54.9% | €162.4m | €11.10 | PS23.4x | E-13.6% | n/a | ||
CYAD | €0.51 | -1.9% | 40.0% | €21.2m | n/a | PS294x | n/a | n/a | ||
ALEMS | €6.20 | -6.8% | -25.0% | €26.2m | n/a | PB2.6x | n/a | n/a | ||
OXUR | €0.23 | -4.2% | -94.3% | €836.8k | n/a | PS10x | n/a | n/a | ||
TUB | €144.40 | -2.3% | 95.9% | €6.4b | €164.00 | PE71.4x | n/a | 0.7% | ||
BIOS | €0.0052 | -7.1% | -87.8% | €1.9m | n/a | PE-0.3x | n/a | n/a |